1 Min Read
June 8 (Reuters) - Can Fite Biopharma Ltd
* Can-Fite concludes successful clinical investigator meeting for its acrobat phase III trial of piclidenoson in the treatment of rheumatoid arthritis Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.